Subscribe for email alerts
Donate to Science & Enterprise
|
By Alan, on May 24th, 2013% Richard Lerner (Scripps Research Institute)
Researchers at Scripps Research Institute in La Jolla, California and Scripps Korea Antibody Institute developed a new process to more rapidly identify antibodies that target specific disease molecules. The team from the lab of Richard Lerner, an immunochemistry professor at and former director of Scripps, published its findings yesterday . . . → Read More: Faster Process Developed to Find Therapeutic Antibodies
By Alan, on May 23rd, 2013% Biosensor smartphone and cradle (Brian Cunningham, University of Illinois)
Engineers at University of Illinois in Urbana created a system harnessing an iPhone’s camera to turn the phone into a biosensor that can detect proteins, bacteria, viruses, and toxins. The team led by engineering professor and entrepreneur Brian Cunningham published its findings in a . . . → Read More: Smartphone Biosensor Devised to Detect Toxins, Pathogens
By Alan, on May 23rd, 2013% Airborne wind turbine prototype (Makani Power Inc.)
Makani Power Inc., a company in Alameda, California developing airborne wind energy systems that fly in the air like kites, was acquired by Google, according to the company’s Web site. Financial terms of the acquisition were not disclosed.
The company says its wind energy system operates . . . → Read More: Airborne Wind Energy Systems Company Acquired by Google
By Alan, on May 22nd, 2013% (Genome.gov)
The Mayo Clinic in Rochester, Minnesota and Cancer Genetics Inc. in Rutherford, New Jersey formed OncoSpire Genomics, a joint venture to develop personalized cancer diagnostics based on next-generation genomic sequencing. Financial aspects of the deal were not disclosed.
Cancer Genetics develops tests to discover genetic abnormalities, particularly those leading to personalized management . . . → Read More: Mayo Clinic, Cancer Genetics Form Cancer Diagnostics Venture
By Alan, on May 22nd, 2013% (National Institutes of Health)
A clinical trial testing a new asthma drug by the pharmaceutical companies Sanofi in Paris and Regeneron Pharmaceuticals in Tarrytown, New York shows the drug sharply cut the rate of asthma exacerbations or attacks compared to a placebo in patients with moderate to severe forms of the disease. The . . . → Read More: Clinical Trial Shows Antibody Effective with Severe Asthma
By Alan, on May 21st, 2013% The global pharmaceutical company GlaxoSmithKline (GSK) is holding a competition for academic partners to conduct drug discovery research, with the winners receiving an opportunity to develop the therapy with the company. The Discovery Fast Track program aims to speed up the drug discovery process and is open to academic researchers in the U.S. and Canada.
. . . → Read More: GSK Holds Challenge for Academic Drug Discovery Partners
By Alan, on May 21st, 2013% Graphene molecular illustration (Lawrence Berkeley National Laboratory)
Materials scientists at Northwestern University in Illinois developed an ink made of a graphene solution that can print patterns for electronic circuits and maintain their conductivity even after folding. The team led by engineering professor Mark Hersam published its findings online in a recent issue of . . . → Read More: Inkjet Printing Process Devised for Graphene Circuits
By Alan, on May 20th, 2013% Dysonics chief technologist Robert Dalton demonstrates the company’s audio app and headphone device (University of California, Davis).
A two year-old company spun-off from University California in Davis is designing a new type of audio experience based on research in the school’s engineering department. Dysonics Inc., located in San Francisco, was founded by three Davis . . . → Read More: Start-Up Creating Audio Technology from UC Davis Research
By Alan, on May 20th, 2013% Example of peripherally inserted central catheter (AHRQ.gov)
Medical researchers at University of Michigan in Ann Arbor found a widely used catheter for intravenous (IV) drug delivery is linked to a higher risk of deep vein blood clots, particularly among critically ill patients or those with cancer. The findings of the team led by . . . → Read More: IV Catheters Linked to Blood Clot Risk in Sickest Patients
By Alan, on May 14th, 2013% (A. Kotok)
Science Business will take a break for a few days, to recharge our batteries — lithium-ion and otherwise. We will return to regular posting next Monday, 20 May.
* * *
|
Welcome to Science & Enterprise Science and Enterprise is an online news service begun in 2010, created for researchers and business people interested in taking scientific knowledge to the marketplace.
On the site’s posts published six days a week, you find research discoveries destined to become new products and services, as well as news about finance, intellectual property, regulations, and employment.
|
You must be logged in to post a comment.